Sarepta Therapeutics | SRPT - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
Acadia Pharmaceuticals USD 8.06M 277K 2026-03
Agios Pharmaceuticals USD 10.8M 1.62M 2026-03
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Daiichi Sankyo JPY 9.96B 230M 2024-03
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 95M 0 2026-03
Incyte USD 38.12M 4.43M 2026-06
Insmed USD 765K 55K 2024-09
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Moderna USD 72M 2M 2026-03
Nektar Therapeutics USD -0.18 0.07 2024-09
Novavax USD 303K 27K 2021-12
Pfizer USD -0.04 115M 2026-06
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sanofi EUR 77M 17M 2026-06
Sarepta Therapeutics USD 7M 1.74M 2026-03
Tectonic Therapeutic USD 1.74M 217K 2024-12
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06